Literature DB >> 26849406

Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers.

Tsunekazu Oikawa1.   

Abstract

UNLABELLED: Liver and biliary tract cancers are highly aggressive, are heterogeneous in their phenotypic traits, and result in clinical outcomes that are difficult to manage. Cancers have subpopulations of cells termed "cancer stem cells" (CSCs) that share common intrinsic signaling pathways for self-renewal and differentiation with normal stem cells. These CSCs likely have the potential to evolve over time and to give rise to new genetically and functionally diverse subclones by accumulating genetic mutations. Extrinsic signaling from the tumor microenvironment, including the CSC niche, has been implicated in tumor initiation/progression and heterogeneity through dynamic crosstalk. CSCs have become recognized as pivotal sources of tumor initiation/progression, relapse/metastasis, and chemoresistance.
CONCLUSION: The origins of CSCs are hypothesized to derive from the transformation of normal stem/progenitors and/or from the reprogramming of adult cells that converts them to stem/progenitor traits; however, the precise mechanisms have not yet been fully elucidated. (Hepatology 2016;64:645-651).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 26849406     DOI: 10.1002/hep.28485

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

Review 1.  Pathology of intrahepatic cholangiocarcinoma.

Authors:  Sandrine Vijgen; Benoit Terris; Laura Rubbia-Brandt
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

Review 2.  Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.

Authors:  Gábor Lendvai; Tímea Szekerczés; Idikó Illyés; Réka Dóra; Endre Kontsek; Alíz Gógl; András Kiss; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; Katalin Borka
Journal:  Pathol Oncol Res       Date:  2018-11-17       Impact factor: 3.201

3.  Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.

Authors:  Oriana Lo Re; Julien Douet; Marcus Buschbeck; Caterina Fusilli; Valerio Pazienza; Concetta Panebianco; Carlo Castruccio Castracani; Tommaso Mazza; Giovanni Li Volti; Manlio Vinciguerra
Journal:  Epigenetics       Date:  2018-09-29       Impact factor: 4.528

4.  Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency.

Authors:  Naosuke Yokomichi; Naoshi Nishida; Yuzo Umeda; Fumitaka Taniguchi; Kazuya Yasui; Toshiaki Toshima; Yoshiko Mori; Akihiro Nyuya; Takehiro Tanaka; Takeshi Yamada; Takahito Yagi; Toshiyoshi Fujiwara; Yoshiyuki Yamaguchi; Ajay Goel; Masatoshi Kudo; Takeshi Nagasaka
Journal:  Liver Cancer       Date:  2018-08-21       Impact factor: 11.740

5.  High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells.

Authors:  Kui Chen; Avrilynn Ding; Yu Ding; Anand Ghanekar
Journal:  Biochem Biophys Rep       Date:  2016-08-12

6.  RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines.

Authors:  Martina Berardocco; Annalisa Radeghieri; Sara Busatto; Marialucia Gallorini; Chiara Raggi; Clarissa Gissi; Igea D'Agnano; Paolo Bergese; Armando Felsani; Anna C Berardi
Journal:  Oncotarget       Date:  2017-08-24

7.  Isolated cancer stem cells from human liver cancer: morphological and functional characteristics in primary culture.

Authors:  M Hu; M Li; H Huang; C Lu
Journal:  Clin Transl Oncol       Date:  2021-06-24       Impact factor: 3.405

8.  HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial-mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation.

Authors:  Wei Tian; Jiatong Li; Zhuo Wang; Tong Zhang; Ying Han; Yanyan Liu; Wenfeng Chu; Yu Liu; Baofeng Yang
Journal:  Acta Pharm Sin B       Date:  2021-04-02       Impact factor: 11.413

9.  Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis.

Authors:  Zewen Zhou; Lunan Qi; Qiuyan Mo; Yingchun Liu; Xianguo Zhou; Zihan Zhou; Xiumei Liang; Shixiong Feng; Hongping Yu
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

Review 10.  New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.

Authors:  Maria Consiglia Bragazzi; Lorenzo Ridola; Samira Safarikia; Sabina Di Matteo; Daniele Costantini; Lorenzo Nevi; Vincenzo Cardinale
Journal:  Ann Gastroenterol       Date:  2017-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.